Drug Type Small molecule drug |
Synonyms AXN 1501, AXN1501 |
Target |
Action stimulants |
Mechanism SIRT1 stimulants(NAD-dependent deacetylase sirtuin 1 stimulants), Epigenetic drug |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | South Korea | 21 May 2024 |